Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.
炔烃化合物具有
MCH受体拮抗活性,可用于制备用于治疗代谢性疾病和/或进食障碍的药物组合物,特别是肥胖症和糖尿病。